CRBU Stock Analysis: Buy, Sell, or Hold?
CRBU - Caribou Biosciences, Inc. Common Stock
$2.00
-0.32 (-13.79%)
▼
5d:
-13.42%
30d:
+4.71%
90d:
+11.11%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When CRBU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRBU is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRBU is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRBU is currently trading at $2.00, which is considered fair relative to its 30-day fair value range of $1.92 to $2.23.
Technical Outlook: Technically, CRBU is in a strong uptrend. Immediate support is located at $1.88, while resistance sits at $2.49. Short-term momentum is weak, with the stock down 13.8% recently.
Market Sentiment: CRBU has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+500.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRBU is in a strong uptrend. Immediate support is located at $1.88, while resistance sits at $2.49. Short-term momentum is weak, with the stock down 13.8% recently.
Market Sentiment: CRBU has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+500.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.92 -
$2.23
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-13.8%)
- BULLISH: Trading 500.0% below Wall St target ($12.00)
- WARNING: Recommendation downgraded due to -13.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.92 -
$2.23
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.88
Resistance Level
$2.49
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.43
Wall Street Target
$12.00
(+500.0%)
Revenue Growth (YoY)
1.9%
Share & Embed Analysis
Last updated: June 03, 2026 8:21 PM ET
Data refreshes hourly during market hours. Next update: 9:21 PM
Data refreshes hourly during market hours. Next update: 9:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRBU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Barbara G Mcclung
SELL
6938 shares
2026-02-24
Ruhi Ahmad Khan
SELL
6938 shares
2026-02-24
Timothy P Kelly
SELL
3147 shares
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 60 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 55 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 55 HOLD |
